Biohacking often seems more complicated than it is. In practice, it usually comes down to understanding a few central terms clearly so you can distinguish between solid data, plausible hypotheses, and pure marketing.
This glossary is therefore not a bucket of abbreviations, but a guide. It classifies the most important terms from sleep, movement, nutrition, lab values, study methodology, and supplements in a way that is actually useful in everyday life and when reading studies.
What biohacking means at its core
In the serious sense, biohacking means measuring, prioritizing, and changing things in a targeted way. The core is not buying capsules, but systematically improving sleep, movement, light, nutrition, and stress management based on verifiable markers and realistic goals.
Used soberly, biohacking is neither a miracle cure nor an alternative medicine system. It is more of a working method: you observe a baseline, change one lever, measure again, and check whether anything relevant has improved. Such markers can be subjective, such as sleep quality or energy in daily life, or more objective, such as resting heart rate, VO2max, HbA1c, ApoB, or training performance.
The order matters. For most people, the largest and best-supported effects are not found in exotic molecules, but in basic factors. Regular exercise lowers disease risk and improves cardiorespiratory fitness substantially (in large meta-analyses). Adequate and regular sleep is associated with better metabolic regulation, cognitive performance, and psychological stability; sleep deprivation worsens insulin sensitivity and recovery even in the short term (in several controlled human studies). Morning daylight helps stabilize the circadian rhythm, which can influence sleep timing and alertness (systematic reviews on light therapy and circadian rhythms).
A term is only useful in biohacking if it meets three criteria: measurable, verifiable, and practically relevant. That is exactly why it makes sense to understand terms like HRV, RCT, Zone 2, or ApoB. They help you classify protocols and products more effectively. Anyone who wants to go deeper into the fundamental question can also see the difference between method and trend here: Evidence-based biohacking vs. wellness trends: the clear difference.
The most important terms from sleep, movement, and nutrition
The central everyday terms in biohacking do not come from the supplement shelf, but from training, sleep, and energy availability. If you understand HRV, Zone 2, RED-S, ApoB, and sleep hygiene, you can more quickly recognize which measures are practical and well supported.
HRV stands for heart rate variability. It refers to the variation in time between individual heartbeats. A higher HRV is often interpreted as a sign of better adaptability of the autonomic nervous system, while a lower HRV is more often taken as a sign of stress, sleep deprivation, alcohol, illness, or high training load. Important: HRV is not a general “health score”; it depends strongly on measurement method, time of day, breathing, and device. What matters most is the trend over time under similar conditions, not comparison with other people.
Zone 2 describes moderate endurance training that you can sustain for a relatively long time. In practice, it is often in a range where you can still speak in full sentences, but not completely effortlessly. Such training improves mitochondrial adaptation and endurance capacity and is a basic building block for cardiometabolic health (in training studies and guidelines). The exact physiological definition can vary depending on the model, through lactate, ventilatory thresholds, or heart rate zones. For everyday use, it matters less whether you hit the perfect zone exactly and more that you train regularly at a moderate intensity.
RED-S stands for Relative Energy Deficiency in Sport. It refers to health and performance consequences of insufficient energy availability. This affects not only women, even though cycle changes can be an important clue. Possible consequences include poorer recovery, lower bone health, hormonal disturbances, increased susceptibility to infection, and performance decline (consensus statements and reviews in sports medicine). Especially with ambitious training, this is a much more relevant issue than many “performance” supplements. For readers, the context of cycle and recovery also fits here: Biohacking and the female cycle: training, nutrition, and recovery by phase.
ApoB formally belongs in the lab, but it is also important for nutrition and everyday life: it approximates the number of atherogenic lipoprotein particles and can reflect atherosclerosis risk more precisely than LDL-C alone (guidelines, meta-analyses, and genetic evidence). That makes ApoB a term you should know before most social-media molecules.
And sleep hygiene? It sounds banal, but it is often more effective than trend supplements: fixed sleep times, a cool dark bedroom, less alcohol in the evening, morning light, less bright light in the evening, and regular exercise. Many of these measures have consistent human evidence; the effect sizes are individual, but in everyday life they are often larger than those of hyped capsules.
Evidence hierarchy: which studies are actually useful
Not every study says the same thing. For questions of effectiveness, randomized controlled trials and well-done meta-analyses are usually more informative than observational, animal, or cell studies; effect size and who it applies to also matter.
RCT stands for randomized controlled trial. Participants are randomly assigned to an intervention or a control group. This reduces bias and makes it more likely that differences are actually due to the intervention. RCTs are especially important when someone claims that a supplement, fasting protocol, or training method “works.” Still, RCTs are not automatically strong: small sample sizes, short duration, poor blinding, or unsuitable endpoints can limit their informative value.
Meta-analyses combine several studies and can therefore provide a more stable overall picture. But they are only as good as the studies included. If many small, heterogeneous, or methodologically weak papers are pooled, weak evidence does not automatically become strong evidence. That is why the question of population, duration, dose, and endpoints is also crucial in meta-analyses.
Observational studies are useful for identifying associations. They often show, for example, that people with more exercise, better sleep, or a more favorable cardiometabolic profile are healthier in the long term. But they do not prove causality. People who exercise more usually differ in several ways from less active people at the same time.
Animal and cell studies are mainly hypothesis generators. If a molecule affects lifespan in mice or activates a signaling pathway in cell culture, that is scientifically interesting, but not yet proof of a clinically relevant benefit in humans. This is exactly where much biohacking marketing starts.
Another often overlooked metric is effect size, such as Cohen-d. It helps classify whether a difference is small, medium, or large. A statistically significant effect can be so small that it barely matters in everyday life. Anyone who wants to read carefully should therefore not only ask: “Is there a study?” but also: How strong was the effect, in whom, compared with what, and for how long? More on the distinction between methodology and measurement fetishism can also be found here: Biohacking vs. quantified self: differences, overlap, and history.
Supplements and molecules: what the abbreviations mean
For supplements, the rule is: first check human evidence, then dose, duration, safety, and interactions. Especially for new longevity molecules, the clinical data are often much thinner than marketing suggests, while some classic substances are better studied in humans.
NMN stands for nicotinamide mononucleotide. It is marketed as a precursor to NAD+. NAD+ is a central coenzyme in energy metabolism and is involved in numerous cellular processes. But that does not automatically mean that raising it through supplementation brings clinically relevant benefits in humans. There are early human studies on NMN, some with hints of changes in NAD-related biomarkers or individual metabolic parameters, but the evidence base is still limited: mostly small samples, short durations, and few hard endpoints. Claims about longevity, performance enhancement, or broad anti-aging benefits are not yet robustly supported.
The same applies to NAD+ itself: a lab or tissue level is not automatically the same as a deficiency that needs treatment. Many marketing claims skip the step from biological plausibility to clinical relevance.
CYP enzymes are liver enzymes involved in breaking down many medications. Some supplements and plant compounds can inhibit or activate these enzymes. As a result, drug levels can rise or fall. In practice, this means that anyone taking medication should not assess supplements in isolation based on influencer recommendations. Interactions are especially important, among others, with anticoagulants, certain antidepressants, immunosuppressants, and some heart medications.
For better-studied substances, the picture is more sober but clearer: creatine improves strength and high-intensity performance in several RCTs, especially when combined with training. Typical doses are often 3–5 g daily; a loading phase of about 20 g/day for 5–7 days is also used in studies. In healthy people, creatine is generally considered well studied at these ranges; in kidney disease or unclear kidney function, it should be medically clarified.
Caffeine improves alertness as well as endurance and sprint performance in several meta-analyses. Commonly studied doses are 3–6 mg/kg body weight about 30–90 minutes before exercise. Side effects can include nervousness, palpitations, stomach upset, and sleep disturbances; special caution is advisable in pregnancy and in people with arrhythmias, anxiety disorders, or sleep problems.
Omega-3 fatty acids are also better studied than many longevity trends, but they depend strongly on population, dose, and endpoint. For elevated triglycerides, studies and guidelines usually use 2–4 g EPA/DHA per day. Possible issues include gastrointestinal complaints and, depending on product and dose, potential interactions with anticoagulant therapies. In short: optimize basics first, then supplement in a targeted and context-dependent way.
Reading lab values and body data correctly
A measurement is only useful if you know exactly what it measures, what influences it, and how it changes over time. In practice, trend, context, and measurement standardization are usually more important than a single isolated numerical value.
ApoB and LDL-C are often confused. LDL-C measures the amount of cholesterol within LDL particles. ApoB, by contrast, approximates the number of atherogenic particles, because each of these particles typically carries one ApoB molecule. Why does this matter? For the vessel wall, it is not only important how much cholesterol is transported, but also how many particles are circulating at all. In guidelines and analyses, ApoB is therefore increasingly regarded as a strong risk marker, especially when LDL-C and triglycerides do not give a fully clear picture.
HbA1c describes average blood glucose over the last about 8–12 weeks. That is useful, but not the whole story. Two people can have the same HbA1c value and still differ greatly in daily patterns, postprandial spikes, sleep quality, muscle mass, and activity. For prevention or self-monitoring, HbA1c is therefore more of one building block than the complete answer.
VO2max measures maximal oxygen uptake under load and is a central marker of endurance performance. Higher cardiorespiratory fitness is consistently associated with lower mortality risk in large observational analyses. For everyday life, it is important to know that not every watch measures VO2max accurately, and estimates depend on the algorithm and data quality. More useful than absolute numbers is often the trend under comparable conditions.
Cohen-d is not a lab value, but a metric for interpreting studies. It describes how large the difference between two groups is approximately. In simplified terms, about 0.2 is considered a small effect, 0.5 a medium effect, and 0.8 a larger effect. This does not replace content assessment, but it helps avoid the common mistake of confusing statistical significance with practical value.
For all of these markers, one measurement is rarely enough. Measure if possible with the same method, at similar times of day, and in the same context. Otherwise, you are often comparing measurement noise rather than real change.
Mini table: 20 central terms at a glance
The following table is the short version of the article. It explains 20 central terms briefly and practically so that you can classify studies, lab values, and biohacking claims more quickly.
The selection is intentionally not optimized for “cool” abbreviations, but for usefulness. A good glossary term either helps you prioritize in everyday life or helps you read studies and product claims.
| Term | Short definition | Practical use |
|---|---|---|
| HRV | Variation in the time intervals between heartbeats | More useful for trends in recovery and stress than for single values |
| RHR / resting heart rate | Heart rate at rest | Can reflect fitness, stress, infection onset, or recovery |
| Zone 2 | Moderate endurance training with a load that can be sustained longer | Solid basis for endurance and metabolic health |
| VO2max | Maximal oxygen uptake under load | Important marker of endurance capacity |
| RED-S | Relative energy deficiency in sport | Warning term for performance decline, cycle problems, recovery disturbance |
| ApoB | Marker of the number of atherogenic lipoprotein particles | Helps classify cardiovascular risk more accurately |
| LDL-C | Cholesterol amount in LDL | Standard value, but not identical to particle number |
| HbA1c | Average blood sugar over weeks | Useful for metabolic overview, but not sufficient alone |
| CGM | Continuous glucose monitoring | Can make individual responses to meals and exercise visible |
| RCT | Randomized controlled trial | Important standard for testing efficacy |
| Meta-analysis | Summary of multiple studies | Good for the overall picture, but dependent on study quality |
| Observational study | Captures associations without randomization | Good for hypotheses, not for causal proof |
| Cohen-d | Measure of effect size | Shows roughly how large an effect is |
| p-value | Measure of statistical compatibility with the null hypothesis | Does not say anything directly about practical relevance |
| NAD+ | Coenzyme in energy metabolism | Biologically important, but not automatically sensible to supplement |
| NMN | Precursor of NAD+ | Trend molecule with currently limited human evidence |
| CYP enzymes | Liver enzymes for substance breakdown | Relevant for interactions with medications |
| Omega-3 | EPA/DHA fatty acids | Well studied depending on the goal, but dose-dependent |
| Creatine | Muscle compound related to energy storage | Well supported for strength and high-intensity performance |
| Sleep hygiene | Behavioral rules that support good sleep | Usually higher priority than sleep supplements |
How to quickly check biohacking claims
A good biohacking claim can be checked roughly in less than a minute. The key points are human evidence, effect size, target group, dose, duration, comparison group, and safety — if more than half are missing, skepticism is usually warranted.
The first question is: Are there data in humans? If the answer comes only from cell experiments, animal models, or biochemical plausibility, that is not a reliable basis for practical benefit. That does not mean the idea must be wrong — only that it is not yet well enough supported to derive clear recommendations.
The second question is: What kind of human data? Single case reports and open pilot studies are clearly weaker than RCTs or systematic reviews. For supplements, it also matters whether the study used the advertised product, a comparable dose, and a sufficiently long duration.
The third question is: How large is the effect? A statistically significant difference can be minimal in practice. For example, if a marker shifts slightly but no everyday-relevant endpoints such as sleep quality, performance, symptoms, or clinical risk improve, restraint is sensible.
Then comes the context check: Who did the effect apply to? Young trained men, older people with comorbidities, shift workers, or people with sleep disorders are not the same population. Transferability is not a detail; it is central. Anyone unsure whether biohacking fits their own situation should also look soberly at the limits: Who should start biohacking — and who should not?.
Finally come dose, timing, and safety. Without these details, a claim is practically incomplete. Especially for women in hormonal transition phases, for people taking medication, or under high training loads, context is particularly important; this overview also fits here: Biohacking perimenopause: what works, what doesn’t.
What you should take away
- Biohacking is fundamentally a method, not a supplement shelf: sleep, movement, light, nutrition, and stress management first.
- Terms like HRV, ApoB, RCT, Zone 2, and Cohen-d help you distinguish data from marketing more effectively.
- Human evidence beats hypothesis: animal and cell studies are interesting, but not reliable practical recommendations.
- A measurement without context is weak: trends, the same measurement conditions, and relevant endpoints matter more than single numbers.
- Always think about supplements in terms of: dose, duration, timing, interactions, and contraindications — and only prioritize them when the basics are already in place.